Table 4.
Placebo (n = 12) | Xylitol 7 g (n = 12) | Xylitol 17 g (n = 12) | Xylitol 35 g (n = 12) | ||
---|---|---|---|---|---|
Abdominal pain | No of subjects with symptom | 0 | 0 | 0 | 0 |
max severity * | - | - | - | - | |
Nausea | No of subjects with symptom | 0 | 0 | 0 | 0 |
max severity | - | - | - | - | |
Vomiting | No of subjects with symptom | 0 | 0 | 0 | 0 |
max severity | - | - | - | - | |
Diarrhea | No of subjects with symptom | 0 | 0 | 0 | 0 |
max severity | - | - | - | - | |
Bowel sounds | No of subjects with symptom | 5 | 9 | 8 | 9 |
max severity | 1.4 | 1.0 | 1.25 | 1.0 | |
Bloating | No of subjects with symptom | 0 | 0 | 1 | 1 |
max severity | - | - | 1.0 | 1.0 | |
Eructation | No of subjects with symptom | 0 | 1 | 0 | 0 |
max severity | - | 1.0 | - | - | |
Flatulence | No of subjects with symptom | 0 | 0 | 0 | 0 |
max severity | - | - | - | - |
* severity score 1 = mild; 2 = severe. Gastrointestinal symptoms were assessed by the use of a checklist. Participants were asked to choose between “no symptom” (0 points), “mild symptoms“ (1 point) and “severe symptoms” (2 points) for each item.